Freedom builds mobile solution for pharmaceutical giant

Freedom builds mobile solution for pharmaceutical giant

Sydney-based mobile and wireless application provider Freedom Technologies has been awarded a lucrative contract to implement a mobile sales solution for one of the world's largest pharmaceutical companies, Merck Sharp & Dohme (MSD).

The implementation, which replaces a cumbersome paper-based system, sees more than 2000 MSD sales representatives ultilising a Palm-based solution across Asia, the Middle East and South America.

By using Palm-based handheld devices, the MSD subsidiaries can implement a cost-effective technology-based solution for managing the "out-of-office" requirements of their sales representatives. These requirements include customer relationship management (CRM) information as well as information relating to each sales representative's activities.

With the commercial use of wireless and mobile technology experiencing a sluggish uptake in Freedom's home market, the company has recognised the need to take its solutions abroad, particularly to Asia where mobile applications are fast outstripping PCs.

MSD has approximately 450 representatives in China, 200 in the Philippines, 1000 in South America, 350 in Turkey, and 250 in Egypt.

"Our sales representatives spend most of their time out of the office meeting with 8-16 doctors a day, and need to effectively and efficiently record the result of each meeting," said Craig Lynch, information services manager for MSD Australia.

"The paper-based system burdened the sales representatives and affected the timeliness and quality of the information recorded. Moving to a handheld-based solution will greatly improve the sales representative's ability to capture relevant information at the point of contact, thus removing the need for data to be entered at a later time."

Follow Us

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.
Show Comments